Tonix Pharmaceuticals Holding Corp. 8-K

What Happened

• Tonix Pharmaceuticals Holding Corp. (TNXP) announced its operating results for the quarter and the full year ended December 31, 2025. The company furnished a press release with those results dated March 12, 2026, and filed an 8‑K on March 13, 2026 to disclose the announcement.

Key Details

• Filing date: March 13, 2026 (Form 8‑K, Item 2.02).
• Reporting period: Quarter and year ended December 31, 2025.
• Press release: Furnished as Exhibit 99.01 to the 8‑K (dated March 12, 2026).
• Exhibit list: Exhibit 99.01 (press release) and Inline XBRL cover page filed under Item 9.01.

Why It Matters

• The filing signals that Tonix has released its most recent operating and financial results; these figures (revenue, expenses, cash position, and other operating metrics) can affect investor assessments of near‑term performance and valuation.
• Retail investors should review the March 12, 2026 press release (Exhibit 99.01) and subsequent SEC filings for the specific financial figures and management commentary before making investment decisions.